Fusion of Morpholine and Schiff Base on Novel Benzimidazole Scaffold as Anti-microbial Agents: A Computational Approach and In-vitro Evaluation

Fusion of Morpholine and Schiff Base on Novel Benzimidazole Scaffold as Anti-microbial Agents: A Computational Approach and In-vitro Evaluation Govindaraj Saravanan Parasuraman Pavadai Stalin Arulsamy Natarajan Kiruthiga https://orcid.org/0000-0002-7230-2003 Krishnan Suresh Kumar S. Dhinesh Kumar A. Abarnadevika Aiyalu Rajasekaran Background

Benzimidazole is a well-known bioactive heterocyclic compound with diverse pharmacological properties. In this study, the fusion of morpholine and Schiff base motifs with benzimidazole has been explored to enhance their antimicrobial activity against bacterial and fungal pathogens. Computational methods complement the experimental findings by providing insights into binding interactions and drug-likeness properties.
Aims and Objective

The study aimed to synthesize novel benzimidazole derivatives fused with morpholine and Schiff basesand evaluate their antimicrobial efficacy and drug-likeness properties through experimental assays and computational modeling.
Methods

The titled compounds were synthesized following a multi-step chemical process and characterized by using various spectroscopic techniques. The antimicrobial activity of synthesized motifs was assessed against bacterial and fungal strains using in-vitro assays. Computational docking was performed to evaluate binding affinities with target enzymes, also pharmacokinetic and physicochemical properties were analyzed to determine drug-likeness properties.
Results

Synthesized derivatives demonstrated significant antimicrobial activity, particularly compounds 3b and 3e , which showed potent inhibition of bacterial and fungal pathogens. Computational studies confirmed favorable binding interactions and drug-likeness profiles, correlating well with in-vitro findings.
Conclusion

The study highlights the potential of benzimidazole derivatives fused with morpholine and Schiff bases as promising antimicrobial agents. These findings pave the way for further exploration of their therapeutic applications, particularly in combating antimicrobial resistance.
04 09 2025 e18741045373865 1 10.2174/crossmark_policy openmedicinalchemistryjournal.com benthamopen.com true 0000-0002-7230-2003 Peer Reviewed Single blind Checked with iThenticate 2024-11-25 2025-01-16 2025-01-24 2025-04-09 https://creativecommons.org/licenses/by/4.0/legalcode 10.2174/0118741045373865250314051717 1748519831 https://openmedicinalchemistryjournal.com/VOLUME/19/ELOCATOR/e18741045373865/ https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.pdf https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.pdf https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.pdf https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.pdf https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.pdf https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.pdf https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.pdf https://openmedicinalchemistryjournal.com/contents/volumes/V19/e18741045373865/e18741045373865.xml Antimicrobial resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance Gastrointest. Endosc. Clin. N. Am. Morrison L. 30 619 2020 10.1016/j.giec.2020.06.004 Morrison L, Zembower TR. Antimicrobial resistance. Gastrointest Endosc Clin N Am 2020; 30 (4) : 619-35. J. Infect. Public Health Uddin T.M. 14 1750 2021 10.1016/j.jiph.2021.10.020 Uddin TM, Chakraborty AJ, Khusro A, et al. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. J Infect Public Health 2021; 14 (12) : 1750-66. BMC Health Serv. Res. Yuluğ P.D. 24 650 2024 10.1186/s12913-024-11110-z Yuluğ PD, Öztürk B, Toprak BO, Öztürk E, Köktürk N, Naycı S. Physicians’ irrational attitudes on the antibiotic prescribing for the treatment of COVID-19 in Turkey: A multicenter survey. BMC Health Serv Res 2024; 24 (1) : 650. 10.1596/26707 Bank W. Drug-resistant infections: A threat to our economic future 2017. Treatment Guidelines for antimicrobial use in common syndromes. 2019. Available from: https://www.icmr.gov.in/icmrobject/custom_data/pdf/resource-guidelines/Treatment_Guidelines_2019_Final.pdf Lancet Murray C.J.L. 399 629 2022 10.1016/S0140-6736(21)02724-0 Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022; 399 (10325) : 629-55. Lancet Microbe Ho C.S. 6 100947 2024 10.1016/j.lanmic.2024.07.010 Ho CS, Wong CT, Aung TT, et al. Antimicrobial resistance: A concise update. Lancet Microbe 2024; 6 (1) : 100947. Microb. Biotechnol. Brüssow H. 17 e14510 2024 10.1111/1751-7915.14510 Brüssow H. The antibiotic resistance crisis and the development of new antibiotics. Microb Biotechnol 2024; 17 (7) : e14510. Inorg. Chim. Acta Karci H. 565 121992 2024 10.1016/j.ica.2024.121992 Karci H, Dündar M, Nawaz Z, et al. Sythesis, characterisation, anticancer and antimicrobial activity of Ag-N-heterocyclic carbene complexes containing benzimidazole derivatives. Inorg Chim Acta 2024; 565 : 121992. Protein Sci. Qiu X. 8 2529 1999 10.1110/ps.8.11.2529 Qiu X, Abdel-Meguid SS, Janson CA, Court RI, Smyth MG, Payne DJ. Molecular basis for triclosan activity involves a flipping loop in the active site. Protein Sci 1999; 8 (11) : 2529-32. Afr. J. Biol. Sci. Raut M. 6 1 2024 Raut M, Rahane T, Ranjane M, Kakade S, Dama GY, Mahajan KC. Synthesis and antimicrobial activity of benzimidazole derivatives. Afr J Biol Sci 2024; 6 (2) : 1-9. Med. Chem. Natarajan R. 20 311 2024 10.2174/0115734064253813231025093707 Natarajan R, Kumar P, Subramani A, et al. A critical review on therapeutic potential of benzimidazole derivatives: A privileged scaffold. Med Chem 2024; 20 (3) : 311-51. Acta Crystallogr. D Biol. Crystallogr. Kitamura Y. 65 1098 2009 10.1107/S0907444909029710 Kitamura Y, Ebihara A, Agari Y, Shinkai A, Hirotsu K, Kuramitsu S. Structure of D -alanine- D -alanine ligase from Thermus thermophilus HB8: Cumulative conformational change and enzyme–ligand interactions. Acta Crystallogr D Biol Crystallogr 2009; 65 (10) : 1098-106. J. Mol. Biol. Teplyakov A. 313 1093 2001 10.1006/jmbi.2001.5094 Teplyakov A, Obmolova G, Badet B, Badet-Denisot MA. Channeling of ammonia in glucosamine-6-phosphate synthase 1 1Edited by R. Huber. J Mol Biol 2001; 313 (5) : 1093-102. J. Mol. Struct. Yan Y. 1303 137611 2024 10.1016/j.molstruc.2024.137611 Yan Y, Liu S, An L, Yang Y, Tian G, Bao X. Synthesis, crystal structure, and antimicrobial evaluation of novel 4-oxyquinazoline derivatives containing a benzimidazole moiety. J Mol Struct 2024; 1303 : 137611. Appl. Chem. Eng. Kumar S. 72 1860 2024 10.59429/ace.v7i2.1860 Kumar S, Utsuk PK, Kumar R, Tevatia P. Recent developments in catalytic and antimicrobial applications of benzimidazole Schiff base: A review. Appl Chem Eng 72 (1) 2024; : 1860-0. Bangladesh J. Pharmacol. George S. 9 49 2014 10.3329/bjp.v9i1.16992 George S, Ramzeena MB, Ram SV, Selvaraj SK, Rajan S, Ravi TK. Design, docking, synthesis and anti E. coli screening of novel thiadiazolo thiourea derivatives as possible inhibitors of Enoyl ACP reductase (FabI) enzyme. Bangladesh J Pharmacol 2014; 9 (1) : 49-53. Nat. Rev. Drug Discov. Kitchen D.B. 3 935 2004 10.1038/nrd1549 Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov 2004; 3 (11) : 935-49. Acta Microbiol. Pol. Chmara H. 35 15 1986 Chmara H, Borowski E. Bacteriolytic effect of cessation of glucosamine supply, induced by specific inhibition of glucosamine-6-phosphate synthetase. Acta Microbiol Pol 1986; 35 (1-2) : 15-27. Arch. Microbiol. Milewski S. 145 234 1986 10.1007/BF00443651 Milewski S, Chmara H, Borowski E. Antibiotic tetaine? a selective inhibitor of chitin and mannoprotein biosynthesis in Candida albicans. Arch Microbiol 1986; 145 (3) : 234-40. Coord. Chem. Rev. Mavvaji M. 505 215714 2024 10.1016/j.ccr.2024.215714 Mavvaji M, Akkoc S. Recent advances in the application of heterogeneous catalysts for the synthesis of benzimidazole derivatives. Coord Chem Rev 2024; 505 : 215714. IUCrJ Burley S.K. 11 279 2024 10.1107/S2052252524002604 Burley SK, Piehl DW, Vallat B, Zardecki C. RCSB Protein Data Bank: Supporting research and education worldwide through explorations of experimentally determined and computationally predicted atomic level 3D biostructures. IUCrJ 2024; 11 (3) : 279-86. Phytomedicine Yang J. 130 155732 2024 10.1016/j.phymed.2024.155732 Yang J, Zhang L, He X, Gou X, Zong Z, Luo Y. In vitro and in vivo enhancement effect of glabridin on the antibacterial activity of colistin, against multidrug resistant Escherichia coli strains. Phytomedicine 2024; 130 : 155732. J. Chem. Inf. Comput. Sci. Mendelsohn L.D. 44 2225 2004 10.1021/ci040123t Mendelsohn LD. ChemDraw 8 ultra, windows and macintosh versions. J Chem Inf Comput Sci 2004; 44 (6) : 2225-6. Asian J. Res. Chem. Satpute U.M. 14 92 2021 10.5958/0974-4150.2021.00016.X Satpute UM, Rohane SH. Efficiency of AUTODOCK: In silico study of pharmaceutical drug molecules. Asian J Res Chem 2021; 14 (1) : 92-6. J. Cheminform. Kerstjens A. 14 3 2022 10.1186/s13321-022-00582-y Kerstjens A, Winter DH. LEADD: Lamarckian evolutionary algorithm for de novo drug design. J Cheminform 2022; 14 (1) : 3. J. Mol. Graph. Model. Bharatham N. 74 54 2017 10.1016/j.jmgm.2017.02.014 Bharatham N, Finch KE, Min J, et al. Performance of a docking/molecular dynamics protocol for virtual screening of nutlin-class inhibitors of Mdmx. J Mol Graph Model 2017; 74 : 54-60. Lett. Drug Des. Discov. Kiruthiga N. 18 574 2021 10.2174/1570180817999201209204523 Kiruthiga N, Saravanan G, Selvinthanuja C, Srinivasan K, Sivakumar T. Glycolytic Inhibition and Antidiabetic Activity on Synthesized Flavanone Scaffolds with Computer Aided Drug Designing Tools. Lett Drug Des Discov 2021; 18 (6) : 574-92. Asian J. Res. Chem. Jejurikar B.L. 14 135 2021 10.5958/0974-4150.2021.00025.0 Jejurikar BL, Rohane SH. Drug designing in discovery studio. Asian J Res Chem 2021; 14 (2) : 135-8. Nucleic Acids Res. Jakubec D. 50 W593 2022 10.1093/nar/gkac389 Jakubec D, Skoda P, Krivak R, Novotny M, Hoksza D. PrankWeb 3: Accelerated ligand-binding site predictions for experimental and modelled protein structures. Nucleic Acids Res 2022; 50 (W1) : W593-7. Anticancer. Agents Med. Chem. Panneerselvam T. 23 2022 10.2174/1871520623666221205140328 Panneerselvam T, Kunjiappan S, Govindaraj S, et al. Graph Theoretical analysis, in silico modeling and molecular dynamic studies of (5-((2-chloropyridin-4-yl)oxy)-3-phenyl-1H-pyrazol-1-yl)-2-(4-substituted phenyl)-N,N-dimethylethen-1-amine derivatives for the treatment of breast cancer. Anticancer Agents Med Chem 2022; 23 10.1016/B978-0-12-820045-2.00007-6 Ashenden SK. In The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry 2021; 103-17. Mol. Simul. Amin M.S.N. 46 487 2020 10.1080/08927022.2020.1732961 Amin MSN, Idris MMH, Selvaraj M, et al. Virtual screening, ADME study, and molecular dynamic simulation of chalcone and flavone derivatives as 5-Lipoxygenase (5-LO) inhibitor. Mol Simul 2020; 46 (6) : 487-96. Trends Chem. Verma P. 2 302 2020 10.1016/j.trechm.2020.02.005 Verma P, Truhlar DG. Status and challenges of density functional theory. Trends Chem 2020; 2 (4) : 302-18. J. Mol. Struct. Güntepe F. 1022 204 2012 10.1016/j.molstruc.2012.05.002 Güntepe F, Saraçoğlu H, Çalışkan N, Yüksektepe Ç, Cukurovali A. Synthesis, molecular and crystal structure analysis of 2-bromo-4-chloro-6-{[4-(3-methyl-3-phenyl-cyclobutyl)-thiazol-2-yl]-hydrazonomethyl}-phenol by experimental methods and theoretical calculations. J Mol Struct 2012; 1022 : 204-10. J. Mol. Struct. İnkaya E. 1026 117 2012 10.1016/j.molstruc.2012.05.059 İnkaya E, Dinçer M, Ekici Ö, Cukurovali A. N′-(2-methoxy-benzylidene)-N-[4-(3-methyl-3-phenyl-cyclobutyl)-thiazol-2-yl]-chloro-acetic hydrazide: X-ray structure, spectroscopic characterization and DFT studies. J Mol Struct 2012; 1026 : 117-26. Sustain. Chem. Pharm. Bagaria S.K. 31 100932 2023 10.1016/j.scp.2022.100932 Bagaria SK, Jangir N, Jangid DK. Green and eco-compatible iron nanocatalysed synthesis of benzimidazole: A review. Sustain Chem Pharm 2023; 31 : 100932. Bioorg. Chem. Menteşe E. 101 104002 2020 10.1016/j.bioorg.2020.104002 Menteşe E, Baltaş N, Emirik M. Synthesis, α-glucosidase inhibition and in silico studies of some 4-(5-fluoro-2-substituted-1H-benzimidazol-6-yl)morpholine derivatives. Bioorg Chem 2020; 101 : 104002. Molecules Khan I.A. 27 6012 2022 10.3390/molecules27186012 Khan IA, Saddique FA, Aslam S, et al. Synthesis of novel N-methylmorpholine-substituted benzimidazolium salts as potential α-glucosidase inhibitors. Molecules 2022; 27 (18) : 6012. RSC Advances Mahmood K. 13 11982 2023 10.1039/D3RA00982C Mahmood K, Akhter Z, Perveen F, et al. Synthesis, DNA binding and biological evaluation of benzimidazole Schiff base ligands and their metal( ii ) complexes. RSC Advances 2023; 13 (18) : 11982-99. Antiinfect. Agents Manickavalli E. 20 e230522205141 2022 10.2174/2211352520666220523153545 Manickavalli E, Kiruthiga N, Vivekanandan L, Roy A, Sivakumar T. Computational studies and biological evaluation on synthesized lead 1,3- diphenyl-4,5-dihydro-1h-pyrazole moiety as anti-infective agents. Antiinfect Agents 2022; 20 (5) : e230522205141. Indian J. Pharm. Sci. Sivakumar K.K. 75 463 2013 10.4103/0250-474X.119832 Sivakumar KK, Rajasekharan A, Rao R, Narasimhan B. Synthesis, SAR study and evaluation of mannich and schiff bases of pyrazol-5(4H)-one moiety containing 3-(hydrazinyl)-2-phenylquinazolin-4(3H)-one. Indian J Pharm Sci 2013; 75 (4) : 463-75. Int. J. Environ. Res. Public Health Attique S.A. 16 923 2019 10.3390/ijerph16060923 Attique SA, Hassan M, Usman M, et al. A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension. Int J Environ Res Public Health 2019; 16 (6) : 923. Pathogens Kowalska-Krochmal B. 10 165 2021 10.3390/pathogens10020165 Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathogens 2021; 10 (2) : 165. Acta Otolaryngol. Antunes J. 142 664 2022 10.1080/00016489.2022.2117845 Antunes J, Mendes N, Adónis C, Freire F. Treatment of otomycosis with clotrimazole: Results accordingly with the fungus isolated. Acta Otolaryngol 2022; 142 (9-12) : 664-7. 10.1007/978-3-030-93831-4 Whatley M. In Introduction to Quantitative Analysis for International Educators 2022; 57-74. Aldrich CS, Aldrich DS. Materials used Chemicals Manufacturer. Available from: https://www.scirp.org/journal/papercitationdetails?paperid=52968&JournalID=473 ChemistrySelect Bagheri I. 6 1008 2021 10.1002/slct.202003034 Bagheri I, Mohammadi L, Zadsirjan V, Heravi MM. Organocatalyzed asymmetric Mannich reaction: An update. ChemistrySelect 2021; 6 (5) : 1008-66. Inorg. Chem. Commun. Boulechfar C. 150 110451 2023 10.1016/j.inoche.2023.110451 Boulechfar C, Ferkous H, Delimi A, et al. Schiff bases and their metal Complexes: A review on the history, synthesis, and applications. Inorg Chem Commun 2023; 150 : 110451. Curr. Bioinform. Jakhar R. 15 270 2020 10.2174/1574893615666191219094216 Jakhar R, Dangi M, Khichi A, Chhillar AK. Relevance of molecular docking studies in drug designing. Curr Bioinform 2020; 15 (4) : 270-8. Acta Chim. Slov. Yeşilçayır E. 69 419 2022 10.17344/acsi.2021.7314 Yeşilçayır E, Çelik İ, Şen HT, Gürpınar SS, Eryılmaz M, Ayhan-Kılcıgil G. Novel benzimidazole-based compounds as antimicrobials: Synthesis, molecular docking, molecular dynamics and in silico ADME profile studies. Acta Chim Slov 2022; 69 (2) : 419-29. Eur. J. Med. Chem. Rana P. 208 112757 2020 10.1016/j.ejmech.2020.112757 Rana P, Ghouse SM, Akunuri R, Madhavi YV, Chopra S, Nanduri S. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors. Eur J Med Chem 2020; 208 : 112757. Chemistry Africa Sharma A.D. 5 149 2022 10.1007/s42250-021-00302-3 Sharma AD, Kaur I. Targeting UDP-glycosyltransferase, glucosamine-6-phosphate synthase and chitin synthase by using bioactive 1,8 cineole for “Aspergillosis” fungal disease mutilating COVID-19 patients: Insights from molecular docking, pharmacokinetics and in-vitro studies. Chemistry Africa 2022; 5 (1) : 149-60. Metalloenzymes Nocentini A. 83 2024 10.1016/B978-0-12-823974-2.00009-7 Nocentini A. Chapter 2.6 - d-Alanine-d-alanine ligase. Metalloenzymes 2024; 83-91. Proc. Natl. Acad. Sci. USA Roper D.I. 97 8921 2000 10.1073/pnas.150116497 Roper DI, Huyton T, Vagin A, Dodson G. The molecular basis of vancomycin resistance in clinically relevant Enterococci: Crystal structure of d -alanyl- d -lactate ligase (VanA). Proc Natl Acad Sci USA 2000; 97 (16) : 8921-5. Chem. Biol. Healy V.L. 7 R109 2000 10.1016/S1074-5521(00)00116-2 Healy VL, Lessard IAD, Roper DI, Knox JR, Walsh CT. Vancomycin resistance in enterococci: Reprogramming of the d-Ala–d-Ala ligases in bacterial peptidoglycan biosynthesis. Chem Biol 2000; 7 (5) : R109-19. Science Davies J. 264 375 1994 10.1126/science.8153624 Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264 (5157) : 375-82. Bioorg. Chem. Yang C. 131 106320 2023 10.1016/j.bioorg.2022.106320 Yang C, Liu Y, Tu Y, et al. Chalcone derivatives as xanthine oxidase inhibitors: Synthesis, binding mode investigation, biological evaluation, and ADMET prediction. Bioorg Chem 2023; 131 : 106320. In Silico Pharmacol. Chandran K. 10 14 2022 10.1007/s40203-022-00130-4 Chandran K, Shane DI, Zochedh A, Sultan AB, Kathiresan T. Docking simulation and ADMET prediction based investigation on the phytochemical constituents of Noni (Morinda citrifolia) fruit as a potential anticancer drug. In Silico Pharmacol 2022; 10 (1) : 14. J. Comput. Biol. Chen X. 27 1397 2020 10.1089/cmb.2019.0323 Chen X, Li H, Tian L, Li Q, Luo J, Zhang Y. Analysis of the physicochemical properties of acaricides based on Lipinski’s rule of five. J Comput Biol 2020; 27 (9) : 1397-406. Cytotechnology Capellini F.M. 72 97 2020 10.1007/s10616-019-00360-z Capellini FM, Vencia W, Amadori M, et al. Characterization of MDCK cells and evaluation of their ability to respond to infectious and non-infectious stressors. Cytotechnology 2020; 72 (1) : 97-109. J. Pharmacol. Exp. Ther. Song Y.K. 368 79 2019 10.1124/jpet.118.250225 Song YK, Park JE, Oh Y, et al. Suppression of canine ATP binding cassette ABCB1 in Madin-Darby canine kidney type II cells unmasks human ABCG2-mediated efflux of olaparib. J Pharmacol Exp Ther 2019; 368 (1) : 79-87. Foods Al-Saif A.M. 11 2766 2022 10.3390/foods11182766 Al-Saif AM, Abdel-Sattar M, Aboukarima AM, Eshra DH, Górnik K. Physico-chemical properties prediction of flame seedless grape berries using an artificial neural network model. Foods 2022; 11 (18) : 2766. Mol. Cell. Biochem. Muthiah I. 476 883 2021 10.1007/s11010-020-03953-x Muthiah I, Rajendran K, Dhanaraj P. In silico molecular docking and physicochemical property studies on effective phytochemicals targeting GPR116 for breast cancer treatment. Mol Cell Biochem 2021; 476 (2) : 883-96. Antibiotics Ceramella J. 11 191 2022 10.3390/antibiotics11020191 Ceramella J, Iacopetta D, Catalano A, Cirillo F, Lappano R, Sinicropi MS. A review on the antimicrobial activity of Schiff bases: Data collection and recent studies. Antibiotics 2022; 11 (2) : 191. Virulence Cheung G.Y.C. 12 547 2021 10.1080/21505594.2021.1878688 Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence 2021; 12 (1) : 547-69. Mol. Genet. Genomics Gurovic V.M.S. 296 1299 2021 10.1007/s00438-021-01823-9 Gurovic VMS, Díaz ML, Gallo CA, Dietrich J. Phylogenomics, CAZyome and core secondary metabolome of Streptomyces albus species. Mol Genet Genomics 2021; 296 (6) : 1299-311. Nat. Rev. Microbiol. Denamur E. 19 37 2021 10.1038/s41579-020-0416-x Denamur E, Clermont O, Bonacorsi S, Gordon D. The population genetics of pathogenic Escherichia coli. Nat Rev Microbiol 2021; 19 (1) : 37-54. J. Fungi Talapko J. 7 79 2021 10.3390/jof7020079 Talapko J, Juzbašić M, Matijević T, et al. Candida albicans—the virulence factors and clinical manifestations of infection. J Fungi 2021; 7 (2) : 79. BTRA Scan. Govekar A. 51 1 2022 Govekar A, Sonal SG. Determination of minimum inhibitory concentration by broth dilution method-a review. BTRA Scan 2022; 51 (2) : 1-6. J. AOAC Int. Teixeira M.W.S. 105 1548 2022 10.1093/jaoacint/qsac089 Teixeira MWS, Dias CVB, Kogawa AC. Status of physicochemical and microbiological analytical methods of gatifloxacin: A review. J AOAC Int 2022; 105 (6) : 1548-54. Molecules Shamsudin N.F. 27 1149 2022 10.3390/molecules27041149 Shamsudin NF, Ahmed QU, Mahmood S, et al. Antibacterial effects of flavonoids and their structure-activity relationship study: A comparative interpretation. Molecules 2022; 27 (4) : 1149. Eur. J. Med. Chem. Ansari K.F. 44 2294 2009 10.1016/j.ejmech.2008.01.022 Ansari KF, Lal C. Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents. Eur J Med Chem 2009; 44 (5) : 2294-9. J. Catal. Kajal A. 2013 893512 2013 Kajal A, Bala S, Kamboj S, Sharma N, Saini V. Schiff bases: A versatile pharmacophore. J Catal 2013; 2013 (1) : 893512. J. Biomol. Struct. Dyn. Uddin N. 38 3246 2020 10.1080/07391102.2019.1654924 Uddin N, Rashid F, Ali S, et al. Synthesis, characterization, and anticancer activity of Schiff bases. J Biomol Struct Dyn 2020; 38 (11) : 3246-59. Eur. J. Med. Chem. Qin H.L. 207 112832 2020 10.1016/j.ejmech.2020.112832 Qin HL, Zhang ZW, Ravindar L, Rakesh KP. Antibacterial activities with the structure-activity relationship of coumarin derivatives. Eur J Med Chem 2020; 207 : 112832. J. Mol. Struct. Alterhoni E. 1229 129498 2021 10.1016/j.molstruc.2020.129498 Alterhoni E, Tavman A, Hacioglu M, Şahin O, Seher Birteksöz Tan A. Synthesis, structural characterization and antimicrobial activity of Schiff bases and benzimidazole derivatives and their complexes with CoCl2, PdCl2, CuCl2 and ZnCl2. J Mol Struct 2021; 1229 : 129498. Bioorg. Chem. Aaghaz S. 136 106538 2023 10.1016/j.bioorg.2023.106538 Aaghaz S, Digwal CS, Neshat N, et al. Synthesis, biological evaluation and mechanistic studies of 4-(1,3-thiazol-2-yl)morpholine-benzimidazole hybrids as a new structural class of antimicrobials. Bioorg Chem 2023; 136 : 106538.